44 C-level executives will speak at the conference including 27 CEOs, 7 CFOs, 7 CSOs, 1 CLO, 1 CCO, and 1 CTO. Keynote speakers: David Holveck, president & CEO of Endo Pharmaceuticals, will focus on the challenge of balancing growth and innovation in the rapidly evolving health care landscape (November 16 dinner). Fred Hassan, chairman & CEO of Schering-Plough will engage in an intimate "fireside chat" on the theme "Leadership in a Time of Change: The Next 10 Years in Biotech" (November 17 lunch). A plenary session focused on the past, present, and future state of the biotechnology industry on November 16. Company presentations on November 16 featuring a diverse group of 37 bioscience companies from throughout the Mid-Atlantic region and beyond. A Growth Strategies track on November 16 with sessions on the virtual business model, creative partnering, and developing value for your exit strategy. A Regulatory track on November 16 with sessions on biosimilars, the FDA Amendments Act, and FDA/industry interactions while preparing for a pandemic. A Finance track on November 17 with topics such as navigating the capital markets, cash preservation strategies, and creative financing transactions. A Hot Topics in Business track on November 17 featuring sessions on the redefined role of venture capitalists, impact of health care reform, and building value in a development-stage company.

For health and science reporters:

A Drug Delivery, Device, and Diagnostics track on November 16 with sessions on the role of diagnostics in bioscience technology and health care, new trends in drug delivery, and advancements for the diagnosis and treatment of neurological disorders. A Hot Topics in Science track on November 17 with topics on immunotherapeutics, regenerative medicine, and mitochondrial targets. An Innovation Corridor featuring more than 50 scientific posters from some of the region ™s most innovative young companies and research institutions.

biotech2009/